
# Title 21— FOOD AND DRUGS
### CHAPTER 9— FEDERAL FOOD, DRUG, AND COSMETIC ACT
#### § 355–2. Actions for delays of generic drugs and biosimilar biological products
##### (g) Rule of construction

Nothing in this section, the amendments made by this section, or in section 355–1 of this title , shall be construed as

(1) prohibiting a license holder from providing an eligible product developer access to a covered product in the absence of an authorization under this section; or

(2) in any way negating the applicability of a REMS with ETASU, as otherwise required under such section 355–1 of this title , with respect to such covered product.
